Zoetis Hints At New Monoclonal Antibody For Osteoarthritis Pain

Zoetis recently alluded to a new monoclonal antibody product in the works that could provide long-lasting osteoarthritis (OA) pain control in veterinary patients by targeting nerve growth factor (NGF) in the pain pathway. At the 2019 World Small Animal Veterinary Association (WSAVA) Conference in Toronto in July, the company supported several presentations related to research and development in chronic OA pain, …

Zoetis Announces Itchy Pet Awareness Month

August marks the inaugural Itchy Pet Awareness Month, a campaign spearheaded by Zoetis to raise pet owner awareness about skin disease in dogs and cats. Because they typically are outside more often, pets tend to experience the most severe itch during the summer. Yet many owners don’t realize when the scratching (or biting, licking, chewing, rubbing, gnawing or head shaking) …